<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01562002</url>
  </required_header>
  <id_info>
    <org_study_id>IOBA-05-2010</org_study_id>
    <nct_id>NCT01562002</nct_id>
  </id_info>
  <brief_title>Safety Study of Stem Cell Transplant to Treat Limbus Insufficiency Syndrome</brief_title>
  <official_title>Advanced Therapy for Ocular Surface Reconstruction. Allogenic Limbus Epithelial Stem-cell Transplant vs Bone Marrow Mesenchymal Stem-cell Transplant in Limbus Insufficiency Syndrome. Double-masked Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Instituto Universitario de Oftalmobiología Aplicada</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Valladolid</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centro en Red de Medicina Regenerativa de Castilla y Leon</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Red de Terapia Celular</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Instituto Universitario de Oftalmobiología Aplicada</source>
  <brief_summary>
    <textblock>
      The purpose of the study is to determine whether allogenic bone marrow stem cell transplant
      is safe and effective in the treatment of limbus insufficiency syndrome versus allogenic
      limbus stem cell transplant.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Viability and safety of mesenchymal stem cell transplant</measure>
    <time_frame>1 Year</time_frame>
    <description>Absence of cell metaplasia with phenotype different to corneal or conjunctival as expected, confirmed by corneal impression cytology and in vivo confocal laser ophthalmoscopy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Absence of complications in pre and peri surgical implantation</measure>
    <time_frame>1 Week</time_frame>
    <description>Correct handling and implantation of stem cell with amniotic membrane transplant following an 4 step classification.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement of 2 lines in Best Corrected Visual Acuity</measure>
    <time_frame>12 month</time_frame>
    <description>Improvement in visual acuity compared to baseline values before transplant</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">27</enrollment>
  <condition>Limbus Corneae Insufficiency Syndrome</condition>
  <arm_group>
    <arm_group_label>Bone Marrow mesenchymal stem cell</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Allogenic Bone Marrow mesenchymal stem cell in amniotic membrane transplant</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Allogenic limbal stem cell Transplant</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Stem Cell with Amniotic Membrane Transplant</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Stem Cell with Amniotic Membrane Transplant</intervention_name>
    <description>Single stem cell expansion in amniotic membrane transplant</description>
    <arm_group_label>Bone Marrow mesenchymal stem cell</arm_group_label>
    <arm_group_label>Allogenic limbal stem cell Transplant</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or Female older than 18 years.

          -  Signed Informed consent

          -  Negative pregnancy test at inclusion for any potential childbearing female.

          -  Compromise of contraceptive method during all trial for any potential childbearing
             female.

          -  Diagnosis of Ocular Surface Failure due to Limbus Insufficiency Syndrome, based in any
             of the published characteristics as corneal surface neovascularization, loss of
             corneal transparency, epithelial irregularities, history of punctate keratitis,
             erosions or repetitive ulcers and presence of symptoms and confirmed by the presence
             of epithelial phenotype cells assessed with conjunctival impression cytology.

          -  Availability for all the scheduled visits during the study

        Exclusion Criteria:

          -  Uncontrolled systemic disease (e.g. hypertension or diabetes) or any disease that
             under medical decision might put the patient at risk during the surgery or follow-up
             examinations or may cause any hazard in data analysis.

          -  Active ocular infection in any eye. If the infection can be cured, inclusion can be
             considered after 30 days of inactive infection since its end.

          -  Alterations in lid statics / dynamics or any other pathology (e.g. severe dry eye
             syndrome) except the one that originated the Limbus Insufficience that under medical
             opinion might alter the results. Any of these must be corrected 3 months prior to
             patient inclusion, before reconsidering rescreening.

          -  Limbus insufficiency syndrome which has not been previously treated with all medical
             (not surgical) procedures available.

          -  No availability for all scheduled visits during the study.

          -  Any other circumstance under investigator´s opinion that prevents patient inclusion
             even though normal inclusion and exclusion criteria are met.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Margarita Calonge, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Instituto Universitario de Oftalmobiología Aplicada</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>IOBA</name>
      <address>
        <city>Valladolid</city>
        <zip>47011</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>January 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 22, 2012</study_first_submitted>
  <study_first_submitted_qc>March 22, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 23, 2012</study_first_posted>
  <last_update_submitted>January 7, 2015</last_update_submitted>
  <last_update_submitted_qc>January 7, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 8, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>limbus</keyword>
  <keyword>cornea</keyword>
  <keyword>insufficiency syndrome</keyword>
  <keyword>stem cell transplant</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

